PDLI R&D to Revenue
Pdl Biopharma Inc · R&D to Revenue
PDLI R&D to Revenue
Latest reported13.35%period ending
PDLI FY R&D/Revenue (174.55% → 13.35%)
Latest values, visible window
High-resolution chart · PNG
PDLI r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 13.3462% | |
| 1.5094% | |
| 2.4415% | |
| 1.7859% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 78.8549% | |
| 62.8445% | |
| 61.5185% | |
| 127.6379% | |
| 124.062% | |
| 125.0253% | |
| 65.5975% | |
| 106.0816% | |
| 134.7015% | |
| 148.3568% | |
| 230.6306% | |
| 174.5455% |